Videos | Heart Valve Technology

Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center ...

Home March 24, 2017
Home
News | Cardiovascular Business | Jeff Zagoudis

March 24, 2017 — Facing the reality of not having enough votes to secure its passage, House leadership withdrew the ...

Home March 24, 2017
Home
News | Information Technology

Safe implementation of new technologies and therapies accompany classic patient safety challenges on ECRI Institute's “2017 Top 10 Patient Safety Concerns for Healthcare Organizations.” The report highlights concerns from health information management, clinical decision support and new oral anticoagulants, to long-standing concerns like test result reporting and follow-up and unrecognized patient deterioration.

Home March 24, 2017
Home
News | Cardiac Imaging

At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad range of integrated, patient-centric solutions designed to address the prevention, diagnosis, minimally invasive treatment and chronic care at home of cardiac conditions.

Home March 24, 2017
Home
Videos | FFR Technologies

Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital, detail ...

Home March 23, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

Bleeding complications did not increase for patients with acute coronary syndrome treated with rivaroxaban in addition to an antiplatelet medication compared with patients who received the standard treatment of aspirin plus an antiplatelet drug, according to new research. The research was presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.

Home March 23, 2017
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

March 23, 2017 — Biotronik announced the European launch of the Edora series, its smallest series of pacemakers and ...

Home March 23, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low dose ...

Home March 23, 2017
Home
microbleeds, brain bleeds caused by TAVR
Feature | Heart Valve Technology

March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic valve ...

Home March 23, 2017
Home
News | Pharmaceuticals

In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when given on top of effective statin therapy, had widely varying effects on LDL cholesterol levels and had no benefit on cardiovascular events among those with LDL lower than 100 mg/dL. However, in patients at high cardiovascular risk who had baseline LDL of greater than 100 mg/dL, bococizumab significantly reduced the risk of cardiovascular events by 21 percent compared with placebo, according to research presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.

Home March 22, 2017
Home
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers

March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing ...

Home March 22, 2017
Home
Cardiogard embolic protection system for surgical valve reaplacement
Feature | Embolic Protection Devices

March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove ...

Home March 22, 2017
Home
Technology | Left Atrial Appendage (LAA) Occluders

Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial in the U.S. for its Sierra Ligation System medical device. Aegis developed the Sierra technology in partnership with the Mayo Clinic in Rochester, Minn. Sierra could, with additional clinical research, prove to prevent stroke in patients with atrial fibrillation (AF), according to the company.

Home March 22, 2017
Home
ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC

Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presented ...

Home March 22, 2017
Home
Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology

March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve ...

Home March 22, 2017
Home
Subscribe Now